NCT00661999View on ClinicalTrials.gov

Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

502

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

March 31, 2009

Study Completion Date

March 31, 2009

Conditions
AnemiaLeukemiaLymphomaLymphoproliferative DisorderMultiple Myeloma and Plasma Cell NeoplasmPrecancerous ConditionUnspecified Adult Solid Tumor, Protocol Specific
Interventions
BIOLOGICAL

darbepoetin alfa

Given by injection

DIETARY_SUPPLEMENT

ferrous sulfate

Given by mouth

DRUG

sodium ferric gluconate complex in sucrose

Given by IV

OTHER

placebo

Given by mouth

Trial Locations (2)

55905

Mayo Clinic, Rochester

Unknown

Mayo Clinic in Arizona, Scottsdale

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mayo Clinic

OTHER